Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery

Journal of Cardiovascular Surgery

Volumn 49, Issue 2, 2008, Pages 277-284

  Mirow, N ^a   Zittermann, A ^a   Koertke, H ^a   Maleszka, A ^a   Knobl, H ^a   Coskun, T ^a   Kleesiek, K ^a   Koerfer, R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardiopulmonary bypass; Coagulation; Extracorporeal circulation; Heparin; Platelet activation

Indexed keywords

AOTHEL; BETA THROMBOGLOBULIN; ELASTASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG DOSE REDUCTION; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEPARINIZATION; HUMAN; IMMUNOLOGICAL PARAMETERS; INTRAOPERATIVE PERIOD; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

AGED; ANTICOAGULANTS; ANTITHROMBIN III; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLATELET FACTOR 4; POSTOPERATIVE HEMORRHAGE;

EID: 45149132299     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Forbes CD, Courtney JM. Thrombosis and artificial surfaces. In: Bloom AL, Thomas DP, Tuddenham EGD, editors. Hemostasis and thrombosis. 3rd ed. Vol 2. Edinburgh: Churchill Livingstone;1998. p. 1301-24.
2. Wendel H P, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-50.
3. Wendel HP, Heller W, Hoffmeister HE. Pathway of platelet protection in heparin-coated devices and its significance for cardiac surgery. Trans Soc Biomater 1995;21:281-5.
4. von Segesser LK, Weiss BM, Pasic M, Garcia E, Turina MI. Risk and benefit of low systemic heparinization during open heart operations. Ann Thorac Surg 1994;58:391-7.
5. Pekna M, Hagman L, Halden E, Nilsson UR, Nilsson B, Thelin S. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann Thorac Surg 1994;58:421-4.
6. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson HE. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg 1992;104:642-7.
7. Ovrum E, Mollnes TE, Fosse F, Holen EA, Tangen G, Abdelnoor M et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 1995;110:1623-32.
8. Wendel HP, Heller W, Gallimore MJ, Hoffmeister HE. Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model. Blood Coagul Fibrinolysis 1994;5:673-8.
9. John LC, Rees GM, Kovacs IB. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage. J Thorac Cardiovasc Surg 1993;105:816-22.
10. Kuitunen AH, Heikkila LJ, Salmenpera MT. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anti-coagulation. Ann Thorac Surg 1997;63:438-44.
11. Ninomiya M, Miyaji K, Takamoto S. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg 2003;75:913-7.
12. Ikuta T, Fujii H, Shibata T, Hattori K, Hirai H, Kumano H et al. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg 2004;77:1678-83.
13. Kutay V, Noyan T, Ozcan S, Melek Y, Ekim H, Yakut C. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. J Card Surg 2006;21:572-7.
14. Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F et al. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 2007. [epub ahead of print].
15. Cardoso PF, Yamazaki F, Keshavjee S, Schaefers HJ, Hsieh CM, Wang LS et al. A reevaluation of heparin requirements for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:53-60.
16. von Segesser LK, Weiss BM, Garcia E, Turina MI. Perfusion with low systemic heparinization during resection of descending thoracic aortic aneurysms. Eur J Cardiothorac Surg 1992;6:246-9.
17. von Segesser LK, Weiss BM, Garcia F, von Felten A, Turina MI. Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992;103:790-8; discussion 798-9.
18. Aldea GS, O'Gara P, Shapira OM, Treanor P, Osman A, Patalis E et al. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 1998;65:425-33.
19. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65.